- Not Fee assured
- Verified this account
After qualifying in medicine at Cambridge and Oxford Universities, and general medical training in London, Dr Jeremy Chataway specialised in Neurology over an 8 year period with posts in Edinburgh, Cambridge and London. He took up his post as a Consultant Neurologist in 2001.
He has a large general neurology practice, with specific interests in stroke and multiple sclerosis.
Areas of interest
Headache; stroke; multiple sclerosis.
Current NHS consultant posts held
NHS National Hospital for Neurology and Neurosurgery
He is a Reader in Neurology at University College London. He is particularly interested in treatment trials in multiple sclerosis, and especially progressive MS. He was the Chief Investigator (CI) of the MS-STAT trial of high dose Simvastatin in secondary progressive MS (SPMS) reported in the Lancet in 2014. He is the CI of the currently enrolling MS-SMART trial in SPMS.
He was a member of the recently reported NICE review into MS link. He sits on a number of committees for the UK MS society. He is the newly appointed Clinical Director of the UCL Comprehensive Clinical Trials Unit.
Reference number 3323511
Affiliations / memberships
MA PhD FRCP
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.